These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages. Ngambenjawong C; Cieslewicz M; Schellinger JG; Pun SH J Control Release; 2016 Feb; 224():103-111. PubMed ID: 26772876 [TBL] [Abstract][Full Text] [Related]
3. Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep). Ngambenjawong C; Gustafson HH; Pineda JM; Kacherovsky NA; Cieslewicz M; Pun SH Theranostics; 2016; 6(9):1403-14. PubMed ID: 27375788 [TBL] [Abstract][Full Text] [Related]
15. M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects. Xiao H; Guo Y; Li B; Li X; Wang Y; Han S; Cheng D; Shuai X ACS Cent Sci; 2020 Jul; 6(7):1208-1222. PubMed ID: 32724855 [TBL] [Abstract][Full Text] [Related]
16. Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies. Genard G; Lucas S; Michiels C Front Immunol; 2017; 8():828. PubMed ID: 28769933 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry. Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162 [TBL] [Abstract][Full Text] [Related]
18. Effects of macrophage polarization on gold nanoparticle-assisted plasmonic photothermal therapy. Ali HR; Selim SA; Aili D RSC Adv; 2021 Jul; 11(40):25047-25056. PubMed ID: 35481041 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, Formulation and Characterization of Immunotherapeutic Glycosylated Dendrimer/cGAMP Complexes for CD206 Targeted Delivery to M2 Macrophages in Cold Tumors. Petrovic M; Porcello A; Tankov S; Majchrzak O; Kiening M; Laingoniaina AC; Jbilou T; Walker PR; Borchard G; Jordan O Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145631 [TBL] [Abstract][Full Text] [Related]
20. Reversibly Switchable, pH-Dependent Peptide Ligand Binding via 3,5-Diiodotyrosine Substitutions. Ngambenjawong C; Sylvestre M; Gustafson HH; Pineda JMB; Pun SH ACS Chem Biol; 2018 Apr; 13(4):995-1002. PubMed ID: 29481044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]